New tests for prostate cancer being developed in the UK show promising signs of improving diagnosis and screening for men, according to researchers for the separate programmes.
One “super test” for prostate cancer developed by Cambridge experts identifies whether cancer cells are present, whether the cancer is early or late-stage, slow or aggressive, using a combination of more than 100 prostate-related biomarkers from both urine and blood samples.
